CBU
ANNX icon

CIBC Bancorp USA’s Annexon ANNX Stock Holding History

CIBC Bancorp USA’s Portfolio ANNX Stock Details ANNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$31.1K Buy
+10,208
New +$25.3K ﹤0.01% 1442

Other funds holding ANNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

CIBC Bancorp USA's ANNX Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Annexon (ANNX) in Q3 2025: 10,208 shares worth $31.1K. The stake represents ﹤0.01% of the portfolio and ranks #1442 among its holdings.

144 funds tracked by Wall St. Rank hold ANNX as of Q3 2025.

  • CIBC Bancorp USA held 10,208 shares of Annexon worth $31.1K as of Q3 2025.
  • Annexon was a new CIBC Bancorp USA position in Q3 2025.
  • Annexon made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1442 holding.
  • 144 funds tracked by Wall St. Rank held Annexon as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.